Arpan Ghosh

Arpan Ghosh is an accomplished scientist currently serving as Principal Scientist and Mechanism Identification Team lead at Dyno Therapeutics since May 2021, where responsibilities include experimental planning and validation studies focused on CNS-targeted rAAVs. Prior experience includes roles as Senior Scientist and Scientist II at Vizgen, and a Scientist position at Harvard Medical School, along with postdoctoral fellowships at Yale University and the University of Minnesota. Early career contributions at the International Center for Genetic Engineering and Biotechnology involved research on malaria vaccine candidates and latent tuberculosis biomarkers. Arpan Ghosh holds a Ph.D. in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota, a Master of Science in Biotechnology from the Indian Institute of Technology, Bombay, and a Bachelor of Science in Biochemistry from Delhi University.